PARIS, FRANCE--(Marketwired - March 17, 2017) - DIMA CORP S.A is pleased to announce the acquisition of the Juvederm full license from DermaVita Company, to develop and market cosmetic products under the Juvederm trademark (No 014016737) worldwide, with an immediate launch in the United States of America.
DIMA CORP S.A, headquartered in Luxembourg and operating globally, has a sustained track record of success in the development and international distribution of cosmetic and medical devices. DIMA CORP S.A is committed to employing as many resources as necessary to meet the requirements of this immense opportunity, and to ensure a swift and successful entry to market.
DIMA CORP S.A.'s President, Dimitri Sillam, stated "We are prepared to bring a new dimension to the rapidly growing $121 billion skincare market with sophisticated technologies that reimagine the skincare retail business."
The free "Juvederm" app is the most advanced high-tech diagnostic mobile application available, using photo technology to generate a revolutionary skincare formula for the consumer. After the consumer takes a selfie and answers a few questions, the algorithm will choose 1 of 2 bases and 4 out of 11 active ingredients in order to create their customized cream. Once the algorithm chooses the best combination, the consumer will have a map to find the closest doctor's office where they will have a complimentary consultation to confirm the selected active ingredients.
The 4-in-1 customized cream is the most active cream in the world with more than 17% active ingredients compared to 3% in the best products.
We believe that technology associated with an expert point-of-view will benefit the consumer by delivering targeted skincare for their specific needs, with 660 possible combinations.
"There is a multitude of creams on the market, but the consumer may not be aware of specific skin issues and therefore does not know the correct cream that is best for their skin. The free Juvederm app will solve these issues for women and men across the USA," stated Sillam.
The Juvederm skincare lines will be available exclusively in an anticipated 2000+ doctor's offices across the United States by June, 2017.
For more information, visit: www.juvedermlab.com
About Juvederm:
All Juvederm formulations consist of scientifically researched and proven combinations of active ingredients that act in synergy to predict and optimize the results they were made to target. The products are developed for both professional and home use, produced in Europe and registered according to all standards corresponding to the European regulations for cosmetic products.